{"gene":"CHPT1","run_date":"2026-06-09T22:57:18","timeline":{"discoveries":[{"year":2023,"finding":"Cryo-EM structure of Xenopus laevis CHPT1 (xlCHPT1) determined to ~3.2 Å resolution reveals a homodimer in which each protomer contains 10 transmembrane helices; the first 6 TMs form a cone-shaped enclosure where catalysis occurs, opening to the cytosolic side where CDP-choline and two Mg2+ ions are coordinated. The structure identifies a eukaryote-specific catalytic site and suggests an entryway for the DAG substrate. An internal pseudo two-fold symmetry between TM3-6 and TM7-10 suggests evolutionary origin via gene duplication from a prokaryotic ancestor.","method":"Cryo-electron microscopy structure determination (~3.2 Å); structural analysis of substrate coordination","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1 / Strong — cryo-EM structure at near-atomic resolution with substrate coordination directly visualized; single rigorous paper with structural and mechanistic detail","pmids":["37179328"],"is_preprint":false},{"year":2025,"finding":"Cryo-EM structure of human CHPT1 (hCHPT1) at 3.7 Å reveals a homodimer with N-terminal, catalytic, and dimerization domains per monomer. Structure-guided mutagenesis and biochemical assays identified specific residues in the catalytic domain that determine substrate selectivity: CHPT1 specifically synthesizes PC whereas CEPT1 catalyzes both PC and PE. Cross-species sequence alignment showed that ovipara CHPT1 conserves substrate-selectivity residues with CEPT1, potentially endowing it with bifunctionality.","method":"Cryo-EM structure determination (3.7 Å); sequence analysis; biochemical characterization with site-directed mutagenesis","journal":"Biochemical and biophysical research communications","confidence":"High","confidence_rationale":"Tier 1 / Moderate — cryo-EM structure of human protein combined with mutagenesis and biochemical activity assays; single lab but multiple orthogonal methods","pmids":["40435706"],"is_preprint":false},{"year":2023,"finding":"CRISPR knockout of CHPT1 in U2OS cells reduced PC synthesis by ~50%, equivalent to CEPT1 KO, confirming that CHPT1 in the Golgi apparatus accounts for approximately half of cellular PC synthesis. Unlike CEPT1 KO, CHPT1 KO had no effect on CCTα regulation (no induction of CCTα protein, no dephosphorylation or nuclear membrane relocalization of CCTα) and no effect on lipid droplet biogenesis, demonstrating that PC synthesized specifically by CHPT1 in the Golgi is functionally distinct from ER-derived PC made by CEPT1.","method":"CRISPR-Cas9 knockout; radiolabeled lipid synthesis assays; immunofluorescence; western blotting; PC liposome rescue experiments","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — CRISPR KO with multiple orthogonal readouts (synthesis assays, protein regulation, LD biogenesis), direct comparison with CEPT1 KO controls, and rescue experiment","pmids":["36871755"],"is_preprint":false},{"year":2023,"finding":"CHPT1 is localized to the Golgi apparatus and catalyzes the final step of the Kennedy (CDP-choline) pathway, transferring phosphocholine from CDP-choline to diacylglycerol (DAG) to produce phosphatidylcholine (PC), requiring Mg2+ as cofactor. CEPT1 performs the equivalent reaction in the endoplasmic reticulum and can also synthesize PE, whereas CHPT1 is PC-specific.","method":"CRISPR KO synthesis assays; subcellular fractionation/localization; structural analysis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — enzymatic activity established by knockout + synthesis assay, localization confirmed by multiple papers, substrate specificity confirmed by structure + biochemistry","pmids":["36871755","37179328","40435706"],"is_preprint":false},{"year":2016,"finding":"ERα was identified as a direct transcriptional regulator of CHPT1 via genome-wide chromatin-bound ERα mapping (ChIP-seq). Estrogen stimulation increased CHPT1 expression and phosphatidylcholine synthesis. CHPT1 silencing inhibited anchorage-independent growth and cell proliferation and suppressed early-stage metastasis of tamoxifen-resistant breast cancer cells in a zebrafish xenograft model.","method":"ChIP-seq (genome-wide ERα mapping); gene silencing (siRNA/shRNA); metabolic profiling; zebrafish xenograft model; transcript profiling","journal":"Cancer research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP-seq identifies direct ERα binding at CHPT1 locus; functional silencing with multiple cellular and in vivo readouts; single lab","pmids":["27457520"],"is_preprint":false},{"year":2020,"finding":"In enzalutamide-resistant CRPC cells, a super-enhancer (SE) at the CHPT1 locus drives androgen-independent CHPT1 expression: androgen receptor (AR) shifts from binding a canonical enhancer (in sensitive cells) to a different SE element (in resistant cells). A CHPT1 locus-derived enhancer RNA binds the H3K27ac reader BRD4 to regulate CHPT1 SE activity and gene expression. Increased CHPT1 conferred enzalutamide resistance in vitro and in mice.","method":"H3K27ac ChIP-seq; AR ChIP; RNA pulldown (enhancer RNA–BRD4 interaction); CHPT1 overexpression in cell lines and xenograft mouse models","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP-seq plus functional overexpression in vivo; enhancer RNA–BRD4 binding by pulldown; single lab with multiple orthogonal methods","pmids":["32917955"],"is_preprint":false},{"year":2025,"finding":"CHPT1 overexpression in CRC cells was sufficient to increase PC content and confer a chemoresistant phenotype. Mechanistically, CHPT1-driven PC enrichment was proposed to sustain pro-survival signaling while reducing lysophospholipid-mediated stress. Edelfosine, which disrupts lipid rafts and inhibits the Kennedy pathway upstream of CHPT1, enhanced chemosensitivity in resistant CRC cells.","method":"CHPT1 overexpression in SW620 cells; lipidomic profiling; edelfosine pharmacological treatment; functional drug-sensitivity assays","journal":"Cells","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — gain-of-function overexpression causally links CHPT1 to PC accumulation and resistance phenotype; pharmacological rescue with multiple assays; single lab","pmids":["41827872"],"is_preprint":false},{"year":2025,"finding":"CHPT1 was found to be downregulated in GEM-resistant PDAC cells. Restoring CHPT1 suppressed proliferation, migration, and EMT. Mechanistically, CHPT1 recruited phosphatase PTPN1 to dephosphorylate STAT3 at Y705, thereby inhibiting SLC7A11 transcription and triggering ferroptosis via lipid peroxidation. PTPN1 knockdown abolished CHPT1's tumor-suppressive effects. Combining ferroptosis inducers with gemcitabine synergistically inhibited tumor growth in vitro and in vivo.","method":"Lentiviral CHPT1 overexpression/knockdown; co-immunoprecipitation (CHPT1–PTPN1 interaction); phospho-STAT3 (Y705) western blot; SLC7A11 transcription assays; xenograft mouse model; ferroptosis assays","journal":"Translational oncology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP identifies CHPT1–PTPN1 interaction; epistasis via PTPN1 KD rescue; in vivo validation; single lab","pmids":["41337814"],"is_preprint":false},{"year":2019,"finding":"During autophagy, newly synthesized choline phospholipids (including those produced via CHPT1) are incorporated into autophagosomal membranes as shown by fluorescence and immunogold labeling of propargylcholine-labeled ChoPLs co-localizing with LC3+ autophagosomes. Cells undergoing autophagy exhibited an altered choline phospholipid profile with longer and more unsaturated fatty acid chains.","method":"13C-labeled choline tracing with MRS; fluorescence imaging; immunogold electron microscopy; western blotting; autophagy-modulating drug treatments","journal":"Autophagy","confidence":"Low","confidence_rationale":"Tier 3 / Weak — CHPT1 is named as a Kennedy pathway enzyme in the context of ChoPL incorporation into autophagosomes but the paper's mechanistic experiments focus on PCYT1A; CHPT1-specific functional data are not isolated","pmids":["31517566"],"is_preprint":false}],"current_model":"CHPT1 is a Golgi-localized, Mg2+-dependent cholinephosphotransferase that catalyzes the final, PC-specific step of the Kennedy pathway by transferring phosphocholine from CDP-choline to diacylglycerol; its cryo-EM structure (human and Xenopus) reveals a homodimeric 10-TM architecture with a cytosol-facing catalytic enclosure, and CRISPR-based functional studies show that Golgi-derived PC from CHPT1 uniquely regulates neither CCTα feedback nor lipid droplet biogenesis—functions reserved for the ER paralog CEPT1—while CHPT1 is transcriptionally regulated by ERα and AR super-enhancers in cancer contexts and can interact with PTPN1 to modulate STAT3 phosphorylation and ferroptosis susceptibility."},"narrative":{"mechanistic_narrative":"CHPT1 is a Golgi-resident, Mg2+-dependent cholinephosphotransferase that catalyzes the final step of the Kennedy (CDP-choline) pathway, transferring phosphocholine from CDP-choline onto diacylglycerol to produce phosphatidylcholine [PMID:36871755, PMID:37179328, PMID:40435706]. Cryo-EM structures of the Xenopus and human enzymes reveal a homodimer in which each protomer folds into 10 transmembrane helices, with the first six forming a cone-shaped, cytosol-facing catalytic enclosure that coordinates CDP-choline and two Mg2+ ions and admits the DAG substrate; an internal pseudo two-fold symmetry between the TM3–6 and TM7–10 halves points to an evolutionary origin by gene duplication [PMID:37179328, PMID:40435706]. Structure-guided mutagenesis pinpoints catalytic-domain residues that make CHPT1 strictly PC-specific, distinguishing it from its ER paralog CEPT1, which also synthesizes PE [PMID:40435706, PMID:36871755, PMID:37179328]. Although CHPT1 accounts for roughly half of cellular PC synthesis, the Golgi-derived PC it produces is functionally distinct from ER-derived PC: CHPT1 loss does not feed back on CCTα or affect lipid droplet biogenesis, functions reserved for CEPT1 [PMID:36871755]. In cancer contexts CHPT1 is a transcriptionally regulated effector of lipid metabolism—directly activated by ERα in breast cancer and by an androgen-receptor super-enhancer in castration-resistant prostate cancer to drive PC synthesis and growth or therapy resistance [PMID:27457520, PMID:32917955]—while in pancreatic cancer CHPT1 acts as a tumor suppressor by recruiting the phosphatase PTPN1 to dephosphorylate STAT3 at Y705, repressing SLC7A11 and promoting ferroptosis [PMID:41337814].","teleology":[{"year":2016,"claim":"Established that CHPT1 is a hormonally regulated metabolic gene by showing ERα directly binds its locus and drives PC synthesis and oncogenic growth, framing CHPT1 as a downstream effector of estrogen signaling rather than a constitutive housekeeping enzyme.","evidence":"Genome-wide ERα ChIP-seq, siRNA/shRNA silencing, metabolic profiling, and zebrafish xenograft in tamoxifen-resistant breast cancer cells","pmids":["27457520"],"confidence":"Medium","gaps":["Does not resolve the enzymatic mechanism or subcellular site of CHPT1 action","Causal link between PC synthesis and the growth/metastasis phenotype is correlative"]},{"year":2019,"claim":"Placed Kennedy-pathway choline phospholipid synthesis, including CHPT1-derived species, in the context of autophagosomal membrane biogenesis, raising the question of whether CHPT1 specifically supplies autophagy membranes.","evidence":"13C-choline MRS tracing, propargylcholine labeling with fluorescence and immunogold colocalization with LC3+ autophagosomes","pmids":["31517566"],"confidence":"Low","gaps":["CHPT1-specific functional data not isolated; mechanistic experiments centered on PCYT1A","No knockout or perturbation of CHPT1 itself in this context"]},{"year":2020,"claim":"Showed how CHPT1 expression is rewired during therapy resistance, demonstrating that AR relocates to a CHPT1 super-enhancer in enzalutamide-resistant prostate cancer to drive androgen-independent expression and confer drug resistance.","evidence":"H3K27ac and AR ChIP-seq, enhancer RNA–BRD4 RNA pulldown, and CHPT1 overexpression in cell lines and xenograft mice","pmids":["32917955"],"confidence":"Medium","gaps":["Does not establish whether CHPT1 enzymatic activity (vs. another function) mediates resistance","Single-lab functional validation"]},{"year":2023,"claim":"Defined the core enzymatic identity and compartmental division of labor of CHPT1, establishing it as a Golgi PC-specific cholinephosphotransferase contributing ~half of cellular PC, whose product is functionally distinct from ER-derived PC.","evidence":"CRISPR-Cas9 knockout in U2OS cells with radiolabeled synthesis assays, CCTα regulation readouts, lipid droplet assays, PC liposome rescue, and direct CEPT1 KO comparison","pmids":["36871755"],"confidence":"High","gaps":["Molecular basis of Golgi-versus-ER PC functional specialization not resolved","Does not explain why Golgi PC fails to feed back on CCTα"]},{"year":2023,"claim":"Provided the first near-atomic structural framework for the reaction, revealing a homodimeric 10-TM architecture with a cytosol-facing catalytic enclosure coordinating CDP-choline and two Mg2+ ions, and inferring an entryway for DAG.","evidence":"Cryo-EM structure of Xenopus CHPT1 at ~3.2 Å with structural analysis of substrate coordination","pmids":["37179328"],"confidence":"High","gaps":["DAG binding mode inferred rather than directly visualized","Structure is of the Xenopus ortholog, not human"]},{"year":2025,"claim":"Resolved the structural and residue-level basis of CHPT1 substrate selectivity in the human enzyme, explaining why CHPT1 is PC-specific while CEPT1 is bifunctional for PC and PE.","evidence":"Cryo-EM structure of human CHPT1 at 3.7 Å with structure-guided site-directed mutagenesis, biochemical activity assays, and cross-species sequence alignment","pmids":["40435706"],"confidence":"High","gaps":["Functional consequences of predicted ovipara bifunctionality not tested in vivo","Catalytic transition-state mechanism not directly determined"]},{"year":2025,"claim":"Uncovered a non-canonical, context-dependent tumor-suppressive function in which CHPT1 scaffolds PTPN1 to dephosphorylate STAT3 (Y705), repress SLC7A11, and trigger ferroptosis, contrasting with its pro-tumorigenic roles in other cancers.","evidence":"Lentiviral CHPT1 overexpression/knockdown, CHPT1–PTPN1 co-immunoprecipitation, phospho-STAT3 western blot, SLC7A11 transcription assays, PTPN1-knockdown epistasis, and xenograft ferroptosis assays in PDAC","pmids":["41337814"],"confidence":"Medium","gaps":["Co-IP without reciprocal validation; direct CHPT1–PTPN1 binding interface unmapped","Whether catalytic activity or PC product is required for the PTPN1 scaffold function is unresolved"]},{"year":2025,"claim":"Linked CHPT1-driven PC accumulation to chemoresistance in colorectal cancer, proposing that PC enrichment sustains pro-survival signaling and that upstream Kennedy-pathway inhibition can restore sensitivity.","evidence":"CHPT1 overexpression in SW620 cells, lipidomic profiling, edelfosine pharmacological treatment, and drug-sensitivity assays","pmids":["41827872"],"confidence":"Medium","gaps":["Mechanistic link between PC enrichment and survival signaling is proposed, not directly demonstrated","Edelfosine acts broadly on lipid rafts and the Kennedy pathway, not selectively on CHPT1"]},{"year":null,"claim":"It remains unresolved how a single PC-synthesizing enzyme produces opposing oncogenic and tumor-suppressive outcomes across tissues, and whether its scaffolding of PTPN1 depends on catalytic activity or PC product.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unifying model reconciling context-dependent pro- and anti-tumor roles","Catalytic-versus-scaffold dependence of the CHPT1–PTPN1–STAT3 axis untested","Molecular basis of Golgi PC functional specialization unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0016740","term_label":"transferase activity","supporting_discovery_ids":[0,1,2,3]},{"term_id":"GO:0016787","term_label":"hydrolase activity","supporting_discovery_ids":[2,3]}],"localization":[{"term_id":"GO:0005794","term_label":"Golgi apparatus","supporting_discovery_ids":[2,3]}],"pathway":[{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[2,3]}],"complexes":[],"partners":["PTPN1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q8WUD6","full_name":"Cholinephosphotransferase 1","aliases":["AAPT1-like protein","Diacylglycerol cholinephosphotransferase 1"],"length_aa":406,"mass_kda":45.1,"function":"Catalyzes the final step of de novo phosphatidylcholine (PC) synthesis, i.e. the transfer of choline phosphate from CDP-choline to the free hydroxyl of a diacylglycerol (DAG), producing a PC. It thereby plays a central role in the formation and maintenance of vesicular membranes","subcellular_location":"Golgi apparatus membrane","url":"https://www.uniprot.org/uniprotkb/Q8WUD6/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/CHPT1","classification":"Not Classified","n_dependent_lines":1,"n_total_lines":1208,"dependency_fraction":0.0008278145695364238},"opencell":{"profiled":true,"resolved_as":"","ensg_id":"ENSG00000111666","cell_line_id":"CID000348","localizations":[{"compartment":"cytoplasmic","grade":3},{"compartment":"nucleoplasm","grade":3}],"interactors":[{"gene":"BPGM","stoichiometry":0.2},{"gene":"PGAM1","stoichiometry":0.2},{"gene":"ALG9","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/target/CID000348","total_profiled":1310},"omim":[{"mim_id":"616751","title":"CHOLINE/ETHANOLAMINE PHOSPHOTRANSFERASE 1; CEPT1","url":"https://www.omim.org/entry/616751"},{"mim_id":"616747","title":"CHOLINE PHOSPHOTRANSFERASE 1; CHPT1","url":"https://www.omim.org/entry/616747"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Vesicles","reliability":"Supported"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/CHPT1"},"hgnc":{"alias_symbol":["CPT1"],"prev_symbol":[]},"alphafold":{"accession":"Q8WUD6","domains":[{"cath_id":"1.20.120.1760","chopping":"36-378","consensus_level":"medium","plddt":96.3552,"start":36,"end":378}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q8WUD6","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q8WUD6-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q8WUD6-F1-predicted_aligned_error_v6.png","plddt_mean":90.88},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=CHPT1","jax_strain_url":"https://www.jax.org/strain/search?query=CHPT1"},"sequence":{"accession":"Q8WUD6","fasta_url":"https://rest.uniprot.org/uniprotkb/Q8WUD6.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q8WUD6/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q8WUD6"}},"corpus_meta":[{"pmid":"36698192","id":"PMC_36698192","title":"Exosomes derived from human adipose mesenchymal stem cells ameliorate hepatic fibrosis by inhibiting PI3K/Akt/mTOR pathway and remodeling choline metabolism.","date":"2023","source":"Journal of nanobiotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/36698192","citation_count":106,"is_preprint":false},{"pmid":"31517566","id":"PMC_31517566","title":"De novo phosphatidylcholine synthesis is required for autophagosome membrane formation and maintenance during autophagy.","date":"2019","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/31517566","citation_count":82,"is_preprint":false},{"pmid":"23166334","id":"PMC_23166334","title":"Single ABCA3 mutations increase risk for neonatal respiratory distress syndrome.","date":"2012","source":"Pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/23166334","citation_count":74,"is_preprint":false},{"pmid":"22178194","id":"PMC_22178194","title":"Glycerophospholipid profile in oncogene-induced senescence.","date":"2011","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/22178194","citation_count":52,"is_preprint":false},{"pmid":"27457520","id":"PMC_27457520","title":"Estrogen Receptor α Promotes Breast Cancer by Reprogramming Choline Metabolism.","date":"2016","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/27457520","citation_count":51,"is_preprint":false},{"pmid":"32917955","id":"PMC_32917955","title":"Aberrant activation of super enhancer and choline metabolism drive antiandrogen therapy resistance in prostate cancer.","date":"2020","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/32917955","citation_count":42,"is_preprint":false},{"pmid":"34791246","id":"PMC_34791246","title":"Whole-exome sequencing of a cohort of infertile men reveals novel causative genes in teratozoospermia that are chiefly related to sperm head defects.","date":"2021","source":"Human reproduction (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/34791246","citation_count":42,"is_preprint":false},{"pmid":"33408336","id":"PMC_33408336","title":"Phospholipid dynamics in ex vivo lung cancer and normal lung explants.","date":"2021","source":"Experimental & molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/33408336","citation_count":36,"is_preprint":false},{"pmid":"36871755","id":"PMC_36871755","title":"Differential contributions of phosphotransferases CEPT1 and CHPT1 to phosphatidylcholine homeostasis and lipid droplet biogenesis.","date":"2023","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/36871755","citation_count":26,"is_preprint":false},{"pmid":"26125130","id":"PMC_26125130","title":"The hepatic circadian clock regulates the choline kinase α gene through the BMAL1-REV-ERBα axis.","date":"2015","source":"Chronobiology international","url":"https://pubmed.ncbi.nlm.nih.gov/26125130","citation_count":21,"is_preprint":false},{"pmid":"35754534","id":"PMC_35754534","title":"Transcriptomics-Based Study of Differentially Expressed Genes Related to Fat Deposition in Tibetan and Yorkshire Pigs.","date":"2022","source":"Frontiers in veterinary science","url":"https://pubmed.ncbi.nlm.nih.gov/35754534","citation_count":21,"is_preprint":false},{"pmid":"34741226","id":"PMC_34741226","title":"The Identification of Blood Biomarkers of Chronic Neuropathic Pain by Comparative Transcriptomics.","date":"2021","source":"Neuromolecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/34741226","citation_count":19,"is_preprint":false},{"pmid":"37179328","id":"PMC_37179328","title":"Structure of a eukaryotic cholinephosphotransferase-1 reveals mechanisms of substrate recognition and catalysis.","date":"2023","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/37179328","citation_count":18,"is_preprint":false},{"pmid":"39417902","id":"PMC_39417902","title":"Genetic etiological spectrum of sperm morphological abnormalities.","date":"2024","source":"Journal of assisted reproduction and genetics","url":"https://pubmed.ncbi.nlm.nih.gov/39417902","citation_count":17,"is_preprint":false},{"pmid":"36010649","id":"PMC_36010649","title":"Vitamin B12 Attenuates Changes in Phospholipid Levels Related to Oxidative Stress in SH-SY5Y Cells.","date":"2022","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/36010649","citation_count":16,"is_preprint":false},{"pmid":"38630029","id":"PMC_38630029","title":"Integration of network pharmacology, lipidomics, and transcriptomics analysis to reveal the mechanisms underlying the amelioration of AKT-induced nonalcoholic fatty liver disease by total flavonoids in vine tea.","date":"2024","source":"Food & function","url":"https://pubmed.ncbi.nlm.nih.gov/38630029","citation_count":13,"is_preprint":false},{"pmid":"38061438","id":"PMC_38061438","title":"Lipid characteristics of lung tissue in silicosis rat model were studied based on lipid metabolomics.","date":"2023","source":"Toxicology letters","url":"https://pubmed.ncbi.nlm.nih.gov/38061438","citation_count":12,"is_preprint":false},{"pmid":"37671148","id":"PMC_37671148","title":"Classification of subtypes and identification of dysregulated genes in sepsis.","date":"2023","source":"Frontiers in cellular and infection microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/37671148","citation_count":11,"is_preprint":false},{"pmid":"26840539","id":"PMC_26840539","title":"Identification of Genes and Pathways Associated with Kidney Ischemia-Reperfusion Injury by Bioinformatics Analyses.","date":"2016","source":"Kidney & blood pressure research","url":"https://pubmed.ncbi.nlm.nih.gov/26840539","citation_count":10,"is_preprint":false},{"pmid":"36047070","id":"PMC_36047070","title":"Globozoospermia: A Case Report and Systematic Review of Literature.","date":"2022","source":"The world journal of men's health","url":"https://pubmed.ncbi.nlm.nih.gov/36047070","citation_count":10,"is_preprint":false},{"pmid":"34458952","id":"PMC_34458952","title":"Integrated lipidomic and transcriptomic analysis reveals clarithromycin-induced alteration of glycerophospholipid metabolism in the cerebral cortex of mice.","date":"2021","source":"Cell biology and toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/34458952","citation_count":9,"is_preprint":false},{"pmid":"37758112","id":"PMC_37758112","title":"Plasma lipidome reveals susceptibility and resistance of Pekin ducks to DHAV-3.","date":"2023","source":"International journal of biological macromolecules","url":"https://pubmed.ncbi.nlm.nih.gov/37758112","citation_count":8,"is_preprint":false},{"pmid":"38716374","id":"PMC_38716374","title":"Potential Association of Gut Microbial Metabolism and Circulating mRNA Based on Multiomics Sequencing Analysis in Fetal Growth Restriction.","date":"2024","source":"Mediators of inflammation","url":"https://pubmed.ncbi.nlm.nih.gov/38716374","citation_count":8,"is_preprint":false},{"pmid":"31964590","id":"PMC_31964590","title":"Genetic Polymorphisms of LPCAT1, CHPT1 and PCYT1B and Risk of Neonatal Respiratory Distress Syndrome among a Chinese Han Population.","date":"2020","source":"Pediatrics and neonatology","url":"https://pubmed.ncbi.nlm.nih.gov/31964590","citation_count":7,"is_preprint":false},{"pmid":"37696961","id":"PMC_37696961","title":"Architects of the membrane: structures of eukaryotic choline phosphotransferase 1 and choline/ethanolamine phosphotransferase 1.","date":"2023","source":"Nature structural & molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/37696961","citation_count":6,"is_preprint":false},{"pmid":"40321821","id":"PMC_40321821","title":"Metabolomics and proteomics analyses reveal the role of the glycerophospholipid metabolism pathway in unexplained recurrent spontaneous abortion.","date":"2025","source":"PeerJ","url":"https://pubmed.ncbi.nlm.nih.gov/40321821","citation_count":5,"is_preprint":false},{"pmid":"39545479","id":"PMC_39545479","title":"Clinical measures in chronic neuropathic pain are related to the Kennedy and endocannabinoid pathways.","date":"2024","source":"European journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/39545479","citation_count":4,"is_preprint":false},{"pmid":"39986037","id":"PMC_39986037","title":"Spatial metabolomics revealed multi-organ toxicity and visualize metabolite changes induced by borneol in zebrafish.","date":"2025","source":"The Science of the total environment","url":"https://pubmed.ncbi.nlm.nih.gov/39986037","citation_count":4,"is_preprint":false},{"pmid":"40799908","id":"PMC_40799908","title":"Multi-omics characterization of diabetic nephropathy in the db/db mouse model of type 2 diabetes.","date":"2025","source":"Computational and structural biotechnology journal","url":"https://pubmed.ncbi.nlm.nih.gov/40799908","citation_count":3,"is_preprint":false},{"pmid":"40435706","id":"PMC_40435706","title":"Structural basis for substrate selectivity and evolutionary insights into human choline phosphotransferase 1.","date":"2025","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/40435706","citation_count":2,"is_preprint":false},{"pmid":"41337814","id":"PMC_41337814","title":"The CHPT-pSTAT3-SLC7A11 signaling axis controls progression and ferroptosis susceptibility of pancreatic cancer.","date":"2025","source":"Translational oncology","url":"https://pubmed.ncbi.nlm.nih.gov/41337814","citation_count":1,"is_preprint":false},{"pmid":"41075514","id":"PMC_41075514","title":"Shiwei Longdanhua Capsule protects from hygrothermal condition and influenza infection by suppressing metabolism and inflammatory pathway.","date":"2025","source":"Phytomedicine : international journal of phytotherapy and phytopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/41075514","citation_count":1,"is_preprint":false},{"pmid":"29411327","id":"PMC_29411327","title":"Gene variants of the phosphatidylcholine synthesis pathway do not contribute to RDS in the Chinese population.","date":"2018","source":"World journal of pediatrics : WJP","url":"https://pubmed.ncbi.nlm.nih.gov/29411327","citation_count":1,"is_preprint":false},{"pmid":"41028147","id":"PMC_41028147","title":"Metabolic profiles of squamous cell lung carcinoma and diagnostic model construction.","date":"2025","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/41028147","citation_count":1,"is_preprint":false},{"pmid":"39510003","id":"PMC_39510003","title":"Combined analyses of mRNA and miRNA transcriptome reveal the molecular mechanisms of theca cells physiological differences in geese follicular selection stage.","date":"2024","source":"Poultry science","url":"https://pubmed.ncbi.nlm.nih.gov/39510003","citation_count":1,"is_preprint":false},{"pmid":"40917351","id":"PMC_40917351","title":"Inhibition of CYP450 family 1 subfamily B member 1 (CYP1B1) expression in macrophage reduces the inflammatory response in type 2 diabetes mellitus combined with tuberculosis.","date":"2025","source":"Frontiers in endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/40917351","citation_count":1,"is_preprint":false},{"pmid":"41151701","id":"PMC_41151701","title":"Metabolomics reveals that Da Chuanxiong Formula ameliorates cerebral ischemia/reperfusion injury via regulating membrane phospholipid homeostasis.","date":"2025","source":"Brain research bulletin","url":"https://pubmed.ncbi.nlm.nih.gov/41151701","citation_count":1,"is_preprint":false},{"pmid":"40823179","id":"PMC_40823179","title":"Discovery of lipid metabolism-related diagnostic biomarkers and construction of diagnostic model in steroid-induced osteonecrosis of femoral head.","date":"2025","source":"Open medicine (Warsaw, Poland)","url":"https://pubmed.ncbi.nlm.nih.gov/40823179","citation_count":1,"is_preprint":false},{"pmid":"23302616","id":"PMC_23302616","title":"[Pulmonary surfactant associated gene variants in mixed ethnic population of Han and Zhuang].","date":"2012","source":"Zhonghua er ke za zhi = Chinese journal of pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/23302616","citation_count":1,"is_preprint":false},{"pmid":"41827872","id":"PMC_41827872","title":"Phosphatidylcholine and CHPT1 as Central Drivers of Chemoresistance in Colorectal Cancer: Lipidomic and Functional Insights.","date":"2026","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/41827872","citation_count":0,"is_preprint":false},{"pmid":"38964904","id":"PMC_38964904","title":"[The mechanism of SSO regulating SiO(2)-induced lipid metabolism disorders in macrophages was explored based on lipid metabolomics].","date":"2024","source":"Zhonghua lao dong wei sheng zhi ye bing za zhi = Zhonghua laodong weisheng zhiyebing zazhi = Chinese journal of industrial hygiene and occupational diseases","url":"https://pubmed.ncbi.nlm.nih.gov/38964904","citation_count":0,"is_preprint":false},{"pmid":"40724325","id":"PMC_40724325","title":"Cis-Palmitoleic Acid Regulates Lipid Metabolism via Diacylglycerol Metabolic Shunting.","date":"2025","source":"Foods (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/40724325","citation_count":0,"is_preprint":false},{"pmid":"41634895","id":"PMC_41634895","title":"Multi-omics analysis and experiments validate the tumor-suppressive role of mitochondrial lipid metabolism gene ACSM5 in lung adenocarcinoma and its impact on the immune microenvironment.","date":"2026","source":"Human genomics","url":"https://pubmed.ncbi.nlm.nih.gov/41634895","citation_count":0,"is_preprint":false},{"pmid":"42155267","id":"PMC_42155267","title":"Integrated lipidomics and transcriptomics reveal different lipid profiles and metabolic pathways in cultured fats from porcine subcutaneous adipocytes and fibro-adipogenic progenitors.","date":"2026","source":"Food chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/42155267","citation_count":0,"is_preprint":false},{"pmid":"39997696","id":"PMC_39997696","title":"Effects of Acorns on Subcutaneous Fat Deposition in Yuxi Black Pigs by Transcriptomic Analysis.","date":"2025","source":"Metabolites","url":"https://pubmed.ncbi.nlm.nih.gov/39997696","citation_count":0,"is_preprint":false},{"pmid":"42148089","id":"PMC_42148089","title":"CFD+CD14+ monocytes: potential pathogenic subset in myasthenia gravis uncovered by multi-omics integration and machine learning analysis.","date":"2026","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/42148089","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":29937,"output_tokens":2837,"usd":0.066183,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":10305,"output_tokens":3348,"usd":0.067613,"stage2_stop_reason":"end_turn"},"total_usd":0.133796,"stage1_batch_id":"msgbatch_01ACAxJQabDsht39JXeWG22d","stage2_batch_id":"msgbatch_01QEU22A9U5sbPTgsMzTmvSf","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2023,\n      \"finding\": \"Cryo-EM structure of Xenopus laevis CHPT1 (xlCHPT1) determined to ~3.2 Å resolution reveals a homodimer in which each protomer contains 10 transmembrane helices; the first 6 TMs form a cone-shaped enclosure where catalysis occurs, opening to the cytosolic side where CDP-choline and two Mg2+ ions are coordinated. The structure identifies a eukaryote-specific catalytic site and suggests an entryway for the DAG substrate. An internal pseudo two-fold symmetry between TM3-6 and TM7-10 suggests evolutionary origin via gene duplication from a prokaryotic ancestor.\",\n      \"method\": \"Cryo-electron microscopy structure determination (~3.2 Å); structural analysis of substrate coordination\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — cryo-EM structure at near-atomic resolution with substrate coordination directly visualized; single rigorous paper with structural and mechanistic detail\",\n      \"pmids\": [\"37179328\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Cryo-EM structure of human CHPT1 (hCHPT1) at 3.7 Å reveals a homodimer with N-terminal, catalytic, and dimerization domains per monomer. Structure-guided mutagenesis and biochemical assays identified specific residues in the catalytic domain that determine substrate selectivity: CHPT1 specifically synthesizes PC whereas CEPT1 catalyzes both PC and PE. Cross-species sequence alignment showed that ovipara CHPT1 conserves substrate-selectivity residues with CEPT1, potentially endowing it with bifunctionality.\",\n      \"method\": \"Cryo-EM structure determination (3.7 Å); sequence analysis; biochemical characterization with site-directed mutagenesis\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — cryo-EM structure of human protein combined with mutagenesis and biochemical activity assays; single lab but multiple orthogonal methods\",\n      \"pmids\": [\"40435706\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"CRISPR knockout of CHPT1 in U2OS cells reduced PC synthesis by ~50%, equivalent to CEPT1 KO, confirming that CHPT1 in the Golgi apparatus accounts for approximately half of cellular PC synthesis. Unlike CEPT1 KO, CHPT1 KO had no effect on CCTα regulation (no induction of CCTα protein, no dephosphorylation or nuclear membrane relocalization of CCTα) and no effect on lipid droplet biogenesis, demonstrating that PC synthesized specifically by CHPT1 in the Golgi is functionally distinct from ER-derived PC made by CEPT1.\",\n      \"method\": \"CRISPR-Cas9 knockout; radiolabeled lipid synthesis assays; immunofluorescence; western blotting; PC liposome rescue experiments\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — CRISPR KO with multiple orthogonal readouts (synthesis assays, protein regulation, LD biogenesis), direct comparison with CEPT1 KO controls, and rescue experiment\",\n      \"pmids\": [\"36871755\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"CHPT1 is localized to the Golgi apparatus and catalyzes the final step of the Kennedy (CDP-choline) pathway, transferring phosphocholine from CDP-choline to diacylglycerol (DAG) to produce phosphatidylcholine (PC), requiring Mg2+ as cofactor. CEPT1 performs the equivalent reaction in the endoplasmic reticulum and can also synthesize PE, whereas CHPT1 is PC-specific.\",\n      \"method\": \"CRISPR KO synthesis assays; subcellular fractionation/localization; structural analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — enzymatic activity established by knockout + synthesis assay, localization confirmed by multiple papers, substrate specificity confirmed by structure + biochemistry\",\n      \"pmids\": [\"36871755\", \"37179328\", \"40435706\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"ERα was identified as a direct transcriptional regulator of CHPT1 via genome-wide chromatin-bound ERα mapping (ChIP-seq). Estrogen stimulation increased CHPT1 expression and phosphatidylcholine synthesis. CHPT1 silencing inhibited anchorage-independent growth and cell proliferation and suppressed early-stage metastasis of tamoxifen-resistant breast cancer cells in a zebrafish xenograft model.\",\n      \"method\": \"ChIP-seq (genome-wide ERα mapping); gene silencing (siRNA/shRNA); metabolic profiling; zebrafish xenograft model; transcript profiling\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP-seq identifies direct ERα binding at CHPT1 locus; functional silencing with multiple cellular and in vivo readouts; single lab\",\n      \"pmids\": [\"27457520\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"In enzalutamide-resistant CRPC cells, a super-enhancer (SE) at the CHPT1 locus drives androgen-independent CHPT1 expression: androgen receptor (AR) shifts from binding a canonical enhancer (in sensitive cells) to a different SE element (in resistant cells). A CHPT1 locus-derived enhancer RNA binds the H3K27ac reader BRD4 to regulate CHPT1 SE activity and gene expression. Increased CHPT1 conferred enzalutamide resistance in vitro and in mice.\",\n      \"method\": \"H3K27ac ChIP-seq; AR ChIP; RNA pulldown (enhancer RNA–BRD4 interaction); CHPT1 overexpression in cell lines and xenograft mouse models\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP-seq plus functional overexpression in vivo; enhancer RNA–BRD4 binding by pulldown; single lab with multiple orthogonal methods\",\n      \"pmids\": [\"32917955\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"CHPT1 overexpression in CRC cells was sufficient to increase PC content and confer a chemoresistant phenotype. Mechanistically, CHPT1-driven PC enrichment was proposed to sustain pro-survival signaling while reducing lysophospholipid-mediated stress. Edelfosine, which disrupts lipid rafts and inhibits the Kennedy pathway upstream of CHPT1, enhanced chemosensitivity in resistant CRC cells.\",\n      \"method\": \"CHPT1 overexpression in SW620 cells; lipidomic profiling; edelfosine pharmacological treatment; functional drug-sensitivity assays\",\n      \"journal\": \"Cells\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — gain-of-function overexpression causally links CHPT1 to PC accumulation and resistance phenotype; pharmacological rescue with multiple assays; single lab\",\n      \"pmids\": [\"41827872\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"CHPT1 was found to be downregulated in GEM-resistant PDAC cells. Restoring CHPT1 suppressed proliferation, migration, and EMT. Mechanistically, CHPT1 recruited phosphatase PTPN1 to dephosphorylate STAT3 at Y705, thereby inhibiting SLC7A11 transcription and triggering ferroptosis via lipid peroxidation. PTPN1 knockdown abolished CHPT1's tumor-suppressive effects. Combining ferroptosis inducers with gemcitabine synergistically inhibited tumor growth in vitro and in vivo.\",\n      \"method\": \"Lentiviral CHPT1 overexpression/knockdown; co-immunoprecipitation (CHPT1–PTPN1 interaction); phospho-STAT3 (Y705) western blot; SLC7A11 transcription assays; xenograft mouse model; ferroptosis assays\",\n      \"journal\": \"Translational oncology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP identifies CHPT1–PTPN1 interaction; epistasis via PTPN1 KD rescue; in vivo validation; single lab\",\n      \"pmids\": [\"41337814\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"During autophagy, newly synthesized choline phospholipids (including those produced via CHPT1) are incorporated into autophagosomal membranes as shown by fluorescence and immunogold labeling of propargylcholine-labeled ChoPLs co-localizing with LC3+ autophagosomes. Cells undergoing autophagy exhibited an altered choline phospholipid profile with longer and more unsaturated fatty acid chains.\",\n      \"method\": \"13C-labeled choline tracing with MRS; fluorescence imaging; immunogold electron microscopy; western blotting; autophagy-modulating drug treatments\",\n      \"journal\": \"Autophagy\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — CHPT1 is named as a Kennedy pathway enzyme in the context of ChoPL incorporation into autophagosomes but the paper's mechanistic experiments focus on PCYT1A; CHPT1-specific functional data are not isolated\",\n      \"pmids\": [\"31517566\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"CHPT1 is a Golgi-localized, Mg2+-dependent cholinephosphotransferase that catalyzes the final, PC-specific step of the Kennedy pathway by transferring phosphocholine from CDP-choline to diacylglycerol; its cryo-EM structure (human and Xenopus) reveals a homodimeric 10-TM architecture with a cytosol-facing catalytic enclosure, and CRISPR-based functional studies show that Golgi-derived PC from CHPT1 uniquely regulates neither CCTα feedback nor lipid droplet biogenesis—functions reserved for the ER paralog CEPT1—while CHPT1 is transcriptionally regulated by ERα and AR super-enhancers in cancer contexts and can interact with PTPN1 to modulate STAT3 phosphorylation and ferroptosis susceptibility.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"CHPT1 is a Golgi-resident, Mg2+-dependent cholinephosphotransferase that catalyzes the final step of the Kennedy (CDP-choline) pathway, transferring phosphocholine from CDP-choline onto diacylglycerol to produce phosphatidylcholine [#2, #3]. Cryo-EM structures of the Xenopus and human enzymes reveal a homodimer in which each protomer folds into 10 transmembrane helices, with the first six forming a cone-shaped, cytosol-facing catalytic enclosure that coordinates CDP-choline and two Mg2+ ions and admits the DAG substrate; an internal pseudo two-fold symmetry between the TM3–6 and TM7–10 halves points to an evolutionary origin by gene duplication [#0, #1]. Structure-guided mutagenesis pinpoints catalytic-domain residues that make CHPT1 strictly PC-specific, distinguishing it from its ER paralog CEPT1, which also synthesizes PE [#1, #3]. Although CHPT1 accounts for roughly half of cellular PC synthesis, the Golgi-derived PC it produces is functionally distinct from ER-derived PC: CHPT1 loss does not feed back on CCTα or affect lipid droplet biogenesis, functions reserved for CEPT1 [#2]. In cancer contexts CHPT1 is a transcriptionally regulated effector of lipid metabolism—directly activated by ERα in breast cancer and by an androgen-receptor super-enhancer in castration-resistant prostate cancer to drive PC synthesis and growth or therapy resistance [#4, #5]—while in pancreatic cancer CHPT1 acts as a tumor suppressor by recruiting the phosphatase PTPN1 to dephosphorylate STAT3 at Y705, repressing SLC7A11 and promoting ferroptosis [#7].\",\n  \"teleology\": [\n    {\n      \"year\": 2016,\n      \"claim\": \"Established that CHPT1 is a hormonally regulated metabolic gene by showing ERα directly binds its locus and drives PC synthesis and oncogenic growth, framing CHPT1 as a downstream effector of estrogen signaling rather than a constitutive housekeeping enzyme.\",\n      \"evidence\": \"Genome-wide ERα ChIP-seq, siRNA/shRNA silencing, metabolic profiling, and zebrafish xenograft in tamoxifen-resistant breast cancer cells\",\n      \"pmids\": [\"27457520\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Does not resolve the enzymatic mechanism or subcellular site of CHPT1 action\", \"Causal link between PC synthesis and the growth/metastasis phenotype is correlative\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Placed Kennedy-pathway choline phospholipid synthesis, including CHPT1-derived species, in the context of autophagosomal membrane biogenesis, raising the question of whether CHPT1 specifically supplies autophagy membranes.\",\n      \"evidence\": \"13C-choline MRS tracing, propargylcholine labeling with fluorescence and immunogold colocalization with LC3+ autophagosomes\",\n      \"pmids\": [\"31517566\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"CHPT1-specific functional data not isolated; mechanistic experiments centered on PCYT1A\", \"No knockout or perturbation of CHPT1 itself in this context\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Showed how CHPT1 expression is rewired during therapy resistance, demonstrating that AR relocates to a CHPT1 super-enhancer in enzalutamide-resistant prostate cancer to drive androgen-independent expression and confer drug resistance.\",\n      \"evidence\": \"H3K27ac and AR ChIP-seq, enhancer RNA–BRD4 RNA pulldown, and CHPT1 overexpression in cell lines and xenograft mice\",\n      \"pmids\": [\"32917955\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Does not establish whether CHPT1 enzymatic activity (vs. another function) mediates resistance\", \"Single-lab functional validation\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Defined the core enzymatic identity and compartmental division of labor of CHPT1, establishing it as a Golgi PC-specific cholinephosphotransferase contributing ~half of cellular PC, whose product is functionally distinct from ER-derived PC.\",\n      \"evidence\": \"CRISPR-Cas9 knockout in U2OS cells with radiolabeled synthesis assays, CCTα regulation readouts, lipid droplet assays, PC liposome rescue, and direct CEPT1 KO comparison\",\n      \"pmids\": [\"36871755\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular basis of Golgi-versus-ER PC functional specialization not resolved\", \"Does not explain why Golgi PC fails to feed back on CCTα\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Provided the first near-atomic structural framework for the reaction, revealing a homodimeric 10-TM architecture with a cytosol-facing catalytic enclosure coordinating CDP-choline and two Mg2+ ions, and inferring an entryway for DAG.\",\n      \"evidence\": \"Cryo-EM structure of Xenopus CHPT1 at ~3.2 Å with structural analysis of substrate coordination\",\n      \"pmids\": [\"37179328\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"DAG binding mode inferred rather than directly visualized\", \"Structure is of the Xenopus ortholog, not human\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Resolved the structural and residue-level basis of CHPT1 substrate selectivity in the human enzyme, explaining why CHPT1 is PC-specific while CEPT1 is bifunctional for PC and PE.\",\n      \"evidence\": \"Cryo-EM structure of human CHPT1 at 3.7 Å with structure-guided site-directed mutagenesis, biochemical activity assays, and cross-species sequence alignment\",\n      \"pmids\": [\"40435706\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional consequences of predicted ovipara bifunctionality not tested in vivo\", \"Catalytic transition-state mechanism not directly determined\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Uncovered a non-canonical, context-dependent tumor-suppressive function in which CHPT1 scaffolds PTPN1 to dephosphorylate STAT3 (Y705), repress SLC7A11, and trigger ferroptosis, contrasting with its pro-tumorigenic roles in other cancers.\",\n      \"evidence\": \"Lentiviral CHPT1 overexpression/knockdown, CHPT1–PTPN1 co-immunoprecipitation, phospho-STAT3 western blot, SLC7A11 transcription assays, PTPN1-knockdown epistasis, and xenograft ferroptosis assays in PDAC\",\n      \"pmids\": [\"41337814\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Co-IP without reciprocal validation; direct CHPT1–PTPN1 binding interface unmapped\", \"Whether catalytic activity or PC product is required for the PTPN1 scaffold function is unresolved\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Linked CHPT1-driven PC accumulation to chemoresistance in colorectal cancer, proposing that PC enrichment sustains pro-survival signaling and that upstream Kennedy-pathway inhibition can restore sensitivity.\",\n      \"evidence\": \"CHPT1 overexpression in SW620 cells, lipidomic profiling, edelfosine pharmacological treatment, and drug-sensitivity assays\",\n      \"pmids\": [\"41827872\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanistic link between PC enrichment and survival signaling is proposed, not directly demonstrated\", \"Edelfosine acts broadly on lipid rafts and the Kennedy pathway, not selectively on CHPT1\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"It remains unresolved how a single PC-synthesizing enzyme produces opposing oncogenic and tumor-suppressive outcomes across tissues, and whether its scaffolding of PTPN1 depends on catalytic activity or PC product.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unifying model reconciling context-dependent pro- and anti-tumor roles\", \"Catalytic-versus-scaffold dependence of the CHPT1–PTPN1–STAT3 axis untested\", \"Molecular basis of Golgi PC functional specialization unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016740\", \"supporting_discovery_ids\": [0, 1, 2, 3]},\n      {\"term_id\": \"GO:0016787\", \"supporting_discovery_ids\": [2, 3]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005794\", \"supporting_discovery_ids\": [2, 3]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [2, 3]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"PTPN1\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":4,"faith_total":5,"faith_pct":80.0}}